Innovative MedTech (IMTH) Form 4 INNOVATIVE MEDTECH / Michael Jordan Friedman ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Friedman Michael Jordan

(Last) (First) (Middle)

280 MADISON AVENUE, SUITE 1005

(Street)

NEW YORK NY 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INNOVATIVE MEDTECH, INC. [ IMTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
President

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2021		J		17,694	A	$0.0001	17,694	D
Series A Preferred Stock	03/09/2021		J		4,240	A	$0.0001	4,240	D
Common Stock	03/25/2021		J		3,400,913	A	$0.01	3,418,607	I	By Red Halo, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option	$1.56	05/02/2022	05/02/2022	P		50,000		05/02/2022	05/02/2029	Common Stock	50,000	$1.56	50,000	I	By Red Halo, LLC
Option	$1.56	05/02/2022	05/02/2022	P		100,000		05/02/2022(1)	05/02/2029	Common Stock	100,000	$1.56	150,000	I	By Red Halo, LLC
Option	$2	05/02/2022	05/02/2022	P		150,000		05/02/2022(1)	05/02/2029	Common Stock	150,000	$2	300,000	I	By Red Halo, LLC
Option	$3	05/02/2022	05/02/2022	P		200,000		05/02/2022(1)	05/02/2029	Common Stock	200,000	$3	500,000	I	By Red Halo, LLC
Option	$4	05/02/2022	05/02/2022	P		250,000		05/02/2022(1)	05/02/2029	Common Stock	250,000	$4	750,000	I	By Red Halo, LLC
Option	$5	05/02/2022	05/02/2022	P		300,000		05/02/2022(1)	05/02/2029	Common Stock	300,000	$5	1,050,000	I	By Red Halo, LLC
Option	$6	05/02/2022	05/02/2022	P		350,000		05/02/2022(1)	05/02/2029	Common Stock	350,000	$6	1,400,000	I	By Red Halo, LLC

Explanation of Responses:

1. As described in the issuer's Current Report on Form 8-K filed on May 27, 2022, these options are not exercisable until certain revenue milestones are met by the issuer.

Remarks:

	/s/ Michael Jordan Friedman	06/17/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.